Element Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Element Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,158	Closed	-$415K	–	32
2023 Q3	$415K	Sell	1,158 -1,613	-58%	-$622K	0.04%	215
2023 Q2	$1.05M	Buy	2,771 +151	+6%	+$61.4K	0.07%	204
2023 Q1	$1.26M	Buy	+2,620	New	+$1.23M	0.09%	145
2022 Q4	–	Sell	-494	Closed	-$206K	–	46
2022 Q3	$206K	Hold	494	–	–	0.1%	133
2022 Q2	$245K	Buy	+494	New	+$257K	0.12%	129

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Element Capital Management's BIO Position: Q4 2023 in Review

Element Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 1,158 shares — an estimated $415K sold.

Element Capital Management first reported a position in BIO in Q2 2022 and held it in 5 quarters. The position peaked at $1.26M in Q1 2023. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

Element Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
Element Capital Management sold 1,158 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $415K.
Element Capital Management first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 5 quarters.
Element Capital Management's Bio-Rad Laboratories Class A position peaked at $1.26M in Q1 2023.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.